Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutathione versus tranexamic acid mesotherapy for melasma
IRCT20260801070468N1Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Glutathione mesotherapy with Tranexamic acid mesotherapy (2 arms). Primary endpoint: Melasma Area and Severity Index score. Started Oct 2026; status: recruiting.
02
Drugs
glutathionetranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20260801070468N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260801070468N1.